Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive phase II results for cetrorelix in BPH

Oct. 14, 2004

Novel ALK4/ALK5 inhibitors discovered at Biogen Idec

Oct. 13, 2004

Studies assess fesoterodine myocardial safety, CYP interactions

Oct. 8, 2004

Solifenacin decreases urgency in overactive bladder patients

Oct. 8, 2004

Therapeutic effects and quality of life improvements of darifenacin in overactive bladder patients

Oct. 7, 2004

Sildenafil and antidepressants improve premature ejaculation

Oct. 7, 2004

Single oral doses of palosuran are reported safe in healthy volunteers

Oct. 5, 2004

Phase IIa study of BXL-628 for BPH meets primary endpoint

Sep. 29, 2004

New approvals for tamsulosin formulations

Sep. 27, 2004

GSK researchers describe new SGK-1 inhibitors and their use

Sep. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...